NCT06170229

Brief Summary

The study aims to compare the effects of an education and High Intensity Interval Training program (eHIIT) with the widely used Neuromuscular Exercise and education program (NEMEX-e) on knee OA symptoms and risk factors for cardiovascular disease in people with knee OA and at least one risk factor for developement of cardiovascular disease. The main research questions the study aims to answer are:

  • Is the eHIIT program better than the NEMEX-e program for reducing the risk of cardiovascular disease?
  • Are the two programs equally good at providing improvement in knee symptoms?

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
8mo left

Started Feb 2024

Typical duration for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Feb 2024Dec 2026

First Submitted

Initial submission to the registry

November 28, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 14, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

February 23, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

September 5, 2024

Status Verified

September 1, 2024

Enrollment Period

2.4 years

First QC Date

November 28, 2023

Last Update Submit

September 2, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Maximal oxygen consumption (VO2max)

    Cardiopulmonary exercise test (CPET) on an ergometer bicycle for evaluation maximal oxygen consumption (VO2max) measured in ml/min/kg

    Baseline and Week 12

  • Knee pain

    The Knee injury and Osteoarthritis Outcome Score (KOOS) pain subscale (KOOS-pain), a disease-specific patient-reported instrument designed to assess knee pain in patients with knee osteoarthritis. The KOOS-pain subscale is scored on a 0-100 scale with 100 indicating no pain and 0 indicating extreme pain.

    Baseline and Week 12

Secondary Outcomes (12)

  • Maximal oxygen consumption (VO2max)

    Week 8 and week 26

  • Knee pain

    Week 8 and week 26

  • Body Mass

    Baseline, Week 12 and Week 26

  • Blood Pressure

    Baseline, Week 12 and Week 26

  • Triglyceride concentration

    Baseline, Week 12 and Week 26

  • +7 more secondary outcomes

Other Outcomes (21)

  • Knee-related Quality of Life

    Baseline, week 8, week 12 and week 26

  • Knee Symptoms

    Baseline, week 8, week 12 and week 26

  • Knee Function in Sports and Recreational activities

    Baseline, week 8, week 12 and week 26

  • +18 more other outcomes

Study Arms (2)

Education and High Intensity Interval Training (eHIIT)

ACTIVE COMPARATOR

1 educational session lasting 1 hour. 12 weeks of supervised High Intensity Interval Training (HIIT) 3 times/week.

Behavioral: eHIIT

Neuromuscular exercise and education program (NEMEX-e)

ACTIVE COMPARATOR

2 educational sessions lasting 1 hour each. 8 weeks of supervised Neuromuscular Exercise 2 times/week.

Behavioral: NEMEX-e

Interventions

eHIITBEHAVIORAL

Education and High intensity Interval Training (Aerobic Exercise) The focus of the one educational session is rationale for aerobic exercise, expected physiological effects of aerobic exercise, diet when performing an exercise program, how the knee accommodates to exercise (including potential experience of muscle soreness and how that is different from joint pain), and management of potential knee OA symptom flares. HIIT is an aerobic exercise form. The eHITT protocol consist of eight 2-minute intervals of high intensity training (with the goal to train at a heart rate of at least 80% of HRmax) followed by 2 minutes of moderate training intensity (with the goal to train at a heart rate of at least 60% of HRmax). There will be several types of exercise modalities for aerobic exercise available (treadmills, cross-trainers, row- and cycle ergometers) and participants may choose whichever they prefer.

Education and High Intensity Interval Training (eHIIT)
NEMEX-eBEHAVIORAL

Education and Neuromuscular Exercise The focus of the two educational sessions is on providing knowledge of OA and treatment options to the participants, with a special focus on knee OA, diet, and exercise and its benefits. Furthermore, advice about self-management is given. The exercises are based on neuromuscular principles to improve sensorimotor control and achieve compensatory functional stability. Sensorimotor control is the ability to coordinate muscle activity and maintain functional stability during movement allowing for joint stability during physical activity. Various positions (sitting, lying, standing) are used to achieve the desired postural activity. The overall goal is to obtain muscle control and stability in situations resembling daily life and/or more strenuous activities. The focus is on achieving good quality of the performance in each exercise with appropriate postural orientation (e.g., joint positioned appropriately in relation to each other).

Neuromuscular exercise and education program (NEMEX-e)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18- years
  • Diagnosis of tibiofemoral knee OA according to the American College of Rheumatology criteria
  • Radiographically confirmed diagnosis of tibiofemoral OA based on radiographs not older than 6 months.
  • Average knee pain level ≥ 4 (0=No pain and 10=Worst pain) over the past week (7 days)
  • At least one of following risk factors for development of cardiovascular disease:
  • Body mass index ≥ 30 kg/m2
  • Hypertension (or in treatment of): Systolic ≥ 135 and/or diastolic ≥ 85 mm Hg
  • Elevated HbA1c (or in treatment of): ≥ 130.7 mg/dL (44 mmol/mol)
  • Elevated Triglycerides (or in treatment of): ≥ 150 mg/dL (1.7 mmol/L)
  • Elevated Cholesterol (or in treatment of) (Low density lipides, LDL): LDL ≥ 54 mg/dL (3.0 mmol/L)

You may not qualify if:

  • Contraindication to exercise (e.g., resting systolic blood pressure \> 200 or diastolic blood pressure \> 115, acute or reoccurring chest pain)
  • Unstable body weight the last 3 months (gain/loss outside +/- 5 kg)
  • Planned weight loss (non-pharmacological, pharmacological, and surgical) during study participation
  • Known current cancer
  • Major cardiovascular event within the last 5 years
  • Insulin dependent type 1 or type 2 diabetes
  • Psoriatic, rheumatoid, or gouty arthritis disease
  • Generalized pain syndromes such as fibromyalgia
  • Lumbar or cervical nerve root compression syndromes
  • Scheduled surgery during study participation
  • Treatment with biological medication
  • Impairments that prevent performance in high intensity aerobic exercise
  • Current or planned participation in other health research intervention studies
  • Pregnant/considering pregnancy
  • Any other condition or impairment that, in the opinion of the investigator, makes a potential participant unsuitable for participation or which obstruct participation, such as a large knee joint effusion, uncontrolled diabetes/hypertension, psychiatric or cognitive disorders, language barriers, or opiate dependency.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Parker Institute, Frederiksberg Hospital

Copenhagen, 2000, Denmark

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 28, 2023

First Posted

December 14, 2023

Study Start

February 23, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

September 5, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations